DMAAU:NASDAQ, Drugs Made In America Acquisition Corp.

DMAAU stock overview

Drugs Made In America Acquisition Corp. (DMAAU:NASDAQ) closed at $11.08 on October 22, 2026, unchanged on the day. The stock trades 11.4% below its 52-week high of $12.50 and 7.6% above its 52-week low of $10.30.

Key figures

Price
$11.08
Day change
0.00%
Volume
141
Average volume
56
Market cap
308M+
52-week range
$10.30 – $12.50
50-day average
$10.91
200-day average
$10.73

Price action over the past year

In 252 trading sessions since October 23, 2025, DMAAU closed higher on 20 days (8%). Its best day was June 5, 2026 (+7.83%) and its worst was June 17, 2026 (-6.27%). It never moved 10% or more in a single session. It opened at least 5% above the previous day's high 1 time.

Similar stocks

Find more stocks like DMAAU with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.